Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Albanese

Showing results (1-10 of 238) with videos related to

Pageof 24
Sort By:
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|August 28, 2021
Cueing brain rhythms in Parkinson's diseaseAlberto Albanese
Journal of Neurology, Neurosurgery, and Psychiatry|June 19, 2007
Can falls be prevented in Parkinson's disease?Alberto Albanese
Toxicon : Official Journal of the International Society on Toxinology|February 17, 2009
Discussion of unique properties of botulinum toxinsAlberto Albanese
Parkinsonism & Related Disorders|November 19, 2008
Dystonia: clinical approachAlberto Albanese
Frontiers in Neurology|February 21, 2017
How Many Dystonias? Clinical EvidenceAlberto Albanese
The Lancet. Neurology|May 14, 2011
Cell therapy for Parkinson's disease: have the glory days gone?Alberto Albanese
JAMA|January 6, 2011
Terminology for preparations of botulinum neurotoxins: what a difference a name makesAlberto Albanese
ACP Journal Club|May 3, 2002
Initial bromocriptine did not change mortality in early, mild Parkinson diseaseAlberto Albanese
Neurology. Clinical Practice|August 21, 2018
Standard strategies for diagnosis and treatment of patients with newly diagnosed Parkinson disease: ITALYAlberto Albanese
Nature Reviews. Neurology|June 18, 2016
Clinical guidelines: No more mistaken identities for botulinum neurotoxinsAlberto Albanese
Pageof 24

Showing results (1-10 of 238) with videos related to

Sort By:
Pageof 24
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|August 28, 2021
Cueing brain rhythms in Parkinson's diseaseAlberto Albanese
Journal of Neurology, Neurosurgery, and Psychiatry|June 19, 2007
Can falls be prevented in Parkinson's disease?Alberto Albanese
Toxicon : Official Journal of the International Society on Toxinology|February 17, 2009
Discussion of unique properties of botulinum toxinsAlberto Albanese
Parkinsonism & Related Disorders|November 19, 2008
Dystonia: clinical approachAlberto Albanese
Frontiers in Neurology|February 21, 2017
How Many Dystonias? Clinical EvidenceAlberto Albanese
The Lancet. Neurology|May 14, 2011
Cell therapy for Parkinson's disease: have the glory days gone?Alberto Albanese
JAMA|January 6, 2011
Terminology for preparations of botulinum neurotoxins: what a difference a name makesAlberto Albanese
ACP Journal Club|May 3, 2002
Initial bromocriptine did not change mortality in early, mild Parkinson diseaseAlberto Albanese
Neurology. Clinical Practice|August 21, 2018
Standard strategies for diagnosis and treatment of patients with newly diagnosed Parkinson disease: ITALYAlberto Albanese
Nature Reviews. Neurology|June 18, 2016
Clinical guidelines: No more mistaken identities for botulinum neurotoxinsAlberto Albanese
Pageof 24